Jaguar Health Inc. [JAGX] Is Still Undervalued at $0.33

Jaguar Health Inc. [JAGX] stock is down -3.74 while the S&P 500 has fallen -0.44% on Monday, 12/14/20. While at the time of this article, JAGX ATR is sitting at 0.06, with the beta value at 1.53. This stock’s volatility for the past week remained at 11.59%, while it was 18.74% for the past 30-day period. JAGX has fallen -$0.01 from the previous closing price of $0.34 on volume of 9.73 million shares.

On 10, December 2020, Jaguar Health Announces Adjournment of Its Special Meeting of Stockholders Until Tuesday, December 22, 2020. According to news published on Yahoo Finance, Jaguar to Host Investor Call Thursday, December 17th at 8:30 a.m. Eastern to Allow Management to Review Developments that Have Taken Place Since the Definitive Proxy Statement was Filed .

Analyst Birdseye View:

Before that, on July 11, 2017, Rodman & Renshaw Recapitulated a Buy rating and elevated its amount target to $2.

In the past 52 weeks of trading, this stock has oscillated between a low of $0.19 and a peak of $1.08. Right now, the middling Wall Street analyst 12-month amount mark is $5.00. At the most recent market close, shares of Jaguar Health Inc. [NASDAQ:JAGX] were valued at $0.33.

FUNDAMENTAL ANALYSIS

Jaguar Health Inc. [NASDAQ:JAGX] most recently reported quarterly sales of 2.77 billion, which represented growth of 180.00%. This publicly-traded organization’s revenue is $199,147 per employee, while its income is -$1,328,946 per employee. This company’s Gross Margin is currently 61.10%, its Pretax Margin is -667.15, and its Net Margin is -667.32. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at -99.52, -220.53, -82.93 and -217.73 respectively.

The Principal structure of this organization shows its whole liability to whole principal at 26.89 and the whole liability to whole assets at 20.78. It shows enduring liability to the whole principal at 1.60 and enduring liability to assets at 0.01 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 0.3185 points at 1st support level, the second support level is making up to 0.3051. But as of 1st resistance point, this stock is sitting at 0.3497 and at 0.3675 for 2nd resistance point.

Jaguar Health Inc. [JAGX] reported its earnings at -$0.21 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.11/share signifying the difference of -0.1 and -90.90% surprise value. Comparing the previous quarter ending of 6/29/2020, the stated earnings were -$0.29 calling estimates for -$0.15/share with the difference of -0.14 depicting the surprise of -93.30%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for Jaguar Health Inc. [NASDAQ:JAGX] is 0.40. Likewise, the Quick ratio is also the same, showing Cash ratio at 0.25. Now if looking for a valuation of this stock’s amount to sales ratio it’s 0.69 and it’s amount to book ratio is 4.88.